![]() |
Code of Federal Regulations (Last Updated: May 6, 2024) |
![]() |
Title 42 - Public Health |
![]() |
Chapter IV - Centers for Medicare & Medicaid Services, Department of Health and Human Services |
![]() |
SubChapter H - Health Care Infrastructure and Model Programs |
![]() |
Part 512 - Radiation Oncology Model and End Stage Renal Disease Treatment Choices Model |
![]() |
Subpart B - Radiation Oncology Model |
![]() |
Scope of Ro Episodes Being Tested |
§ 512.230 - Criteria for determining cancer types.
-
§ 512.230 Criteria for determining cancer types.
(a) Included cancer types. CMS includes in the RO Model test cancer types that satisfy all of the following criteria. The cancer type:
(1) Is The cancer type is commonly treated with radiation ; and per nationally recognized, evidence-based clinical treatment guidelines;
(2) Has The cancer type has one or more associated current ICD-10 codes that have demonstrated pricing stability; and
(3) The Secretary has not determined that the cancer type is not suitable for inclusion in the RO Model.
(b) Removing cancer types. CMS removes cancer types in the RO Model if it determines:
(2) CMS discovers a(1) RT is no longer appropriate to treat a cancer type per nationally recognized, evidence-based clinical treatment guidelines;
That there is a ≥10 percent error in established national base rates; or
3(
Secretary determines a2) The
not to be suitable for inclusion in the RO Modelcancer type
does not meet the criteria set forth in paragraph (a) of this section.
(c) ICD-10 codes for included cancer types. CMS displays on the RO Model website no later than 30 days prior to each PY the ICD-10 diagnosis codes associated with each included cancer type.
[85 FR 61362, Sept. 29, 2020, as amended at 86 FR 63996, Nov. 16, 2021]